TFEB and Alzheimer disease: (2012) stating increased lysosomal biogenesis in PSDKO brains, itself objecting to studies showing that increased TFEB-mediated clearance decreases pTau and amyloid levels in AD mouse models (Polito et al., 2014, Xiao et al., 2014), not contributing to their buildup.